Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Allogene Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Allogene Therapeutics Inc
Rating: 1.55841675
Author: Trendlyne DVM scores

about

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...

1.25 0.05 (4.17%)

66.93% Fall from 52W High

3.3M

XNAS Volume

XNAS 26 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.2 / 100

Technically Neutral

48.2 / 100

1Yr Price target upside is 505%

10 analysts

Allogene Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...

66.93% Fall from 52W High

SWOT Analysis

Allogene Therapeutics Inc Live Price Chart